IMMUNE NETWORK

The Korean Association of Immunobiologists (대한면역학회)
권호 표지
DOI QR코드

DOI QR Code

Molecular Mechanisms Governing IL-24 Gene Expression

  • Sahoo, Anupama (School of Life Sciences and Immune Synapse Research Center, Gwangju Institute of Science and Technology (GIST)) ;
  • Im, Sin-Hyeog (School of Life Sciences and Immune Synapse Research Center, Gwangju Institute of Science and Technology (GIST))
  • Received : 2011.12.20
  • Accepted : 2012.01.10
  • Published : 2012.02.29
Download PDF
⟨ Previous Next ⟩

Abstract

Interleukin-24 (IL-24) belongs to the IL-10 family of cytokines and is well known for its tumor suppressor activity. This cytokine is released by both immune and nonimmune cells and acts on non-hematopoietic tissues such as skin, lung and reproductive tissues. Apart from its ubiquitous tumor suppressor function, IL-24 is also known to be involved in the immunopathology of autoimmune diseases like psoriasis and rheumatoid arthritis. Although the cellular sources and functions of IL-24 are being increasingly investigated, the molecular mechanisms of IL-24 gene expression at the levels of signal transduction, epigenetics and transcription factor binding are still unclear. Understanding the specific molecular events that regulate the production of IL-24 will help to answer the remaining questions that are important for the design of new strategies of immune intervention involving IL-24. Herein, we briefly review the signaling pathways and transcription factors that facilitate, induce, or repress production of this cytokine along with the cellular sources and functions of IL-24.

Keywords

References

  1. Boehm U, Klamp T, Groot M, Howard JC: Cellular responses to interferon-gamma. Annu Rev Immunol 15;749-795, 1997. https://doi.org/10.1146/annurev.immunol.15.1.749
  2. Li-Weber M, Krammer PH: Regulation of IL4 gene expression by T cells and therapeutic perspectives. Nat Rev Immunol 3;534-443, 2003. https://doi.org/10.1038/nri1128
  3. Saraiva M, O'Garra A: The regulation of IL-10 production by immune cells. Nat Rev Immunol 10;170-181, 2010. https://doi.org/10.1038/nri2711
  4. Rennick DM, Fort MM, Davidson NJ: Studies with IL-10-/- mice: an overview. J Leukoc Biol 61;389-396, 1997. https://doi.org/10.1002/jlb.61.4.389
  5. Im SH, Hueber A, Monticelli S, Kang KH, Rao A: Chromatin-level regulation of the IL10 gene in T cells. J Biol Chem 279;46818-46825, 2004. https://doi.org/10.1074/jbc.M401722200
  6. Reinemer P, Sebald W, Duschl A: The Interleukin-4-Receptor: From Recognition Mechanism to Pharmacological Target Structure. Angew Chem Int Ed Engl 39;2834-2846, 2000. https://doi.org/10.1002/1521-3773(20000818)39:16<2834::AID-ANIE2834>3.0.CO;2-K
  7. Ricci M, Matucci A, Rossi O: IL-4 as a key factor influencing the development of allergen-specific Th2-like cells in atopic individuals. J Investig Allergol Clin Immunol 7;144-150, 1997.
  8. Schroder K, Hertzog PJ, Ravasi T, Hume DA: Interferongamma: an overview of signals, mechanisms and functions. J Leukoc Biol 75;163-189, 2004.
  9. Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, Stewart TA: Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 259;1739-1742, 1993. https://doi.org/10.1126/science.8456300
  10. Jiang H, Lin JJ, Su ZZ, Goldstein NI, Fisher PB: Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. Oncogene 11; 2477-2486, 1995.
  11. Huang EY, Madireddi MT, Gopalkrishnan RV, Leszczyniecka M, Su Z, Lebedeva IV, Kang D, Jiang H, Lin JJ, Alexandre D, Chen Y, Vozhilla N, Mei MX, Christiansen KA, Sivo F, Goldstein NI, Mhashilkar AB, Chada S, Huberman E, Pestka S, Fisher PB: Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties. Oncogene 20; 7051-7063, 2001. https://doi.org/10.1038/sj.onc.1204897
  12. Chada S, Sutton RB, Ekmekcioglu S, Ellerhorst J, Mumm JB, Leitner WW, Yang HY, Sahin AA, Hunt KK, Fuson KL, Poìndexter N, Roth JA, Ramesh R, Grimm EA, Mhashilkar AM: MDA-7/IL-24 is a unique cytokine--tumor suppressor in the IL-10 family. Int Immunopharmacol 4;649-667, 2004. https://doi.org/10.1016/j.intimp.2004.01.017
  13. Dash R, Bhutia SK, Azab B, Su ZZ, Quinn BA, Kegelmen TP, Das SK, Kim K, Lee SG, Park MA, Yacoub A, Rahmani M, Emdad L, Dmitriev IP, Wang XY, Sarkar D, Grant S, Dent P, Curiel DT, Fisher PB: mda-7/IL-24: a unique member of the IL-10 gene family promoting cancer-targeted toxicity. Cytokine Growth Factor Rev 21;381-391, 2010. https://doi.org/10.1016/j.cytogfr.2010.08.004
  14. Fisher PB: Is mda-7/IL-24 a "magic bullet" for cancer? Cancer Res 65;10128-10138, 2005. https://doi.org/10.1158/0008-5472.CAN-05-3127
  15. Caudell EG, Mumm JB, Poindexter N, Ekmekcioglu S, Mhashilkar AM, Yang XH, Retter MW, Hill P, Chada S, Grimm EA: The protein product of the tumor suppressor gene, melanoma differentiation-associated gene 7, exhibits immunostimulatory activity and is designated IL-24. J Immunol 168;6041-6046, 2002.
  16. Wolk K, Kunz S, Asadullah K, Sabat R: Cutting edge: immune cells as sources and targets of the IL-10 family members? J Immunol 168;5397-5402, 2002. https://doi.org/10.4049/jimmunol.168.11.5397
  17. Sahoo A, Lee CG, Jash A, Son JS, Kim G, Kwon HK, So JS, Im SH: Stat6 and c-Jun mediate Th2 cell-specific IL-24 gene expression. J Immunol 186;4098-4109, 2011. https://doi.org/10.4049/jimmunol.1002620
  18. Schaefer G, Venkataraman C, Schindler U: Cutting edge: FISP (IL-4-induced secreted protein), a novel cytokine-like molecule secreted by Th2 cells. J Immunol 166;5859-5863, 2001. https://doi.org/10.4049/jimmunol.166.10.5859
  19. Maarof G, Bouchet-Delbos L, Gary-Gouy H, Durand- Gasselin I, Krzysiek R, Dalloul A: Interleukin-24 inhibits the plasma cell differentiation program in human germinal center B cells. Blood 115;1718-1726, 2010. https://doi.org/10.1182/blood-2009-05-220251
  20. Andoh A, Shioya M, Nishida A, Bamba S, Tsujikawa T, Kim-Mitsuyama S, Fujiyama Y: Expression of IL-24, an activator of the JAK1/STAT3/SOCS3 cascade, is enhanced in inflammatory bowel disease. J Immunol 183;687-695, 2009. https://doi.org/10.4049/jimmunol.0804169
  21. Kunz S, Wolk K, Witte E, Witte K, Doecke WD, Volk HD, Sterry W, Asadullah K, Sabat R: Interleukin (IL)-19, IL-20 and IL-24 are produced by and act on keratinocytes and are distinct from classical ILs. Exp Dermatol 15;991-1004, 2006. https://doi.org/10.1111/j.1600-0625.2006.00516.x
  22. Ellerhorst JA, Prieto VG, Ekmekcioglu S, Broemeling L, Yekell S, Chada S, Grimm EA: Loss of MDA-7 expression with progression of melanoma. J Clin Oncol 20;1069-1074, 2002. https://doi.org/10.1200/JCO.20.4.1069
  23. Dumoutier L, Renauld JC: Viral and cellular interleukin-10 (IL-10)-related cytokines: from structures to functions. Eur Cytokine Netw 13;5-15, 2002.
  24. Wang M, Liang P: Interleukin-24 and its receptors. Immunology 114;166-170, 2005. https://doi.org/10.1111/j.1365-2567.2005.02094.x
  25. Wang M, Tan Z, Zhang R, Kotenko SV, Liang P: Interleukin 24 (MDA-7/MOB-5) signals through two heterodimeric receptors, IL-22R1/IL-20R2 and IL-20R1/IL-20R2. J Biol Chem 277;7341-7347, 2002. https://doi.org/10.1074/jbc.M106043200
  26. Rømer J, Hasselager E, Nørby PL, Steiniche T, Thorn Clausen J, Kragballe K: Epidermal overexpression of interleukin-19 and -20 mRNA in psoriatic skin disappears after short-term treatment with cyclosporine a or calcipotriol. J Invest Dermatol 121;1306-1311, 2003. https://doi.org/10.1111/j.1523-1747.2003.12626.x
  27. Kragstrup TW, Otkjaer K, Holm C, Jorgensen A, Hokland M, Iversen L, Deleuran B: The expression of IL-20 and IL-24 and their shared receptors are increased in rheumatoid arthritis and spondyloarthropathy. Cytokine 41;16-23, 2008. https://doi.org/10.1016/j.cyto.2007.10.004
  28. Soo C, Shaw WW, Freymiller E, Longaker MT, Bertolami CN, Chiu R, Tieu A, Ting K: Cutaneous rat wounds express c49a, a novel gene with homology to the human melanoma differentiation associated gene, mda-7. Cell Biochem 74; 1-10, 1999. https://doi.org/10.1002/(SICI)1097-4644(19990701)74:1<1::AID-JCB1>3.0.CO;2-M
  29. Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, Sabat R: IL-22 increases the innate immunity of tissues. Immunity 21;241-254, 2004. https://doi.org/10.1016/j.immuni.2004.07.007
  30. Phan RT, Saito M, Basso K, Niu H, Dalla-Favera R: BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells. Nat Immunol 6;1054-1060, 2005. https://doi.org/10.1038/ni1245
  31. He M, Liang P: IL-24 transgenic mice: in vivo evidence of overlapping functions for IL-20, IL-22, and IL-24 in the epidermis. J Immunol 184;1793-1798, 2010. https://doi.org/10.4049/jimmunol.0901829
  32. Wahl C, Muller W, Leithauser F, Adler G, Oswald F, Reimann J, Schirmbeck R, Seier A, Weiss JM, Prochnow B, Wegenka UM: IL-20 receptor 2 signaling down-regulates antigen-specific T cell responses. J Immunol 182;802-810, 2009. https://doi.org/10.4049/jimmunol.182.2.802
  33. Jiang H, Su ZZ, Lin JJ, Goldstein NI, Young CS, Fisher PB: The melanoma differentiation associated gene mda-7 suppresses cancer cell growth. Proc Natl Acad Sci U S A 93; 9160-9165, 1996. https://doi.org/10.1073/pnas.93.17.9160
  34. Kreis S, Philippidou D, Margue C, Behrmann I: IL-24: a classic cytokine and/or a potential cure for cancer? J Cell Mol Med 12;2505-2510, 2008. https://doi.org/10.1111/j.1582-4934.2008.00372.x
  35. Sarkar D, Su ZZ, Lebedeva IV, Sauane M, Gopalkrishnan RV, Valerie K, Dent P, Fisher PB: mda-7 (IL-24) Mediates selective apoptosis in human melanoma cells by inducing the coordinated overexpression of the GADD family of genes by means of p38 MAPK. Proc Natl Acad Sci U S A 99;10054-10059, 2002. https://doi.org/10.1073/pnas.152327199
  36. Gupta P, Walter MR, Su ZZ, Lebedeva IV, Emdad L, Randolph A, Valerie K, Sarkar D, Fisher PB: BiP/GRP78 is an intracellular target for MDA-7/IL-24 induction of cancer- specific apoptosis. Cancer Res 66;8182-8191, 2006. https://doi.org/10.1158/0008-5472.CAN-06-0577
  37. Sieger KA, Mhashilkar AM, Stewart A, Sutton RB, Strube RW, Chen SY, Pataer A, Swisher SG, Grimm EA, Ramesh R, Chada S: The tumor suppressor activity of MDA-7/IL-24 is mediated by intracellular protein expression in NSCLC cells. Mol Ther 9;355-367, 2004.
  38. Lebedeva IV, Emdad L, Su ZZ, Gupta P, Sauane M, Sarkar D, Staudt MR, Liu SJ, Taher MM, Xiao R, Barral P, Lee SG, Wang D, Vozhilla N, Park ES, Chatman L, Boukerche H, Ramesh R, Inoue S, Chada S, Li R, De Pass AL, Mahasreshti PJ, Dmitriev IP, Curiel DT, Yacoub A, Grant S, Dent P, Senzer N, Nemunaitis JJ, Fisher PB: mda-7/IL-24, novel anticancer cytokine: focus on bystander antitumor, radiosensitization and antiangiogenic properties and overview of the phase I clinical experience (Review). Int J Oncol 31; 985-1007, 2007.
  39. Lebedeva IV, Su ZZ, Sarkar D, Gopalkrishnan RV, Waxman S, Yacoub A, Dent P, Fisher PB: Induction of reactive oxygen species renders mutant and wild-type K-ras pancreatic carcinoma cells susceptible to Ad.mda-7-induced apoptosis. Oncogene 24;585-596, 2005. https://doi.org/10.1038/sj.onc.1208183
  40. Lebedeva IV, Su ZZ, Sarkar D, Kitada S, Dent P, Waxman S, Reed JC, Fisher PB: Melanoma differentiation associated gene-7, mda-7/interleukin-24, induces apoptosis in prostate cancer cells by promoting mitochondrial dysfunction and inducing reactive oxygen species. Cancer Res 63;8138-8144, 2003.
  41. Ramesh R, Ito I, Gopalan B, Saito Y, Mhashilkar AM, Chada S: Ectopic production of MDA-7/IL-24 inhibits invasion and migration of human lung cancer cells. Mol Ther 9;510-518, 2004. https://doi.org/10.1016/j.ymthe.2004.01.019
  42. Ramesh R, Mhashilkar AM, Tanaka F, Saito Y, Branch CD, Sieger K, Mumm JB, Stewart AL, Boquoi A, Dumoutier L, Grimm EA, Renauld JC, Kotenko S, Chada S: Melanoma differentiation-associated gene 7/interleukin (IL)-24 is a novel ligand that regulates angiogenesis via the IL-22 receptor. Cancer Res 63;5105-5113, 2003.
  43. Cunningham CC, Chada S, Merritt JA, Tong A, Senzer N, Zhang Y, Mhashilkar A, Parker K, Vukelja S, Richards D, Hood J, Coffee K, Nemunaitis J: Clinical and local biological effects of an intratumoral injection of mda-7 (IL24; INGN 241) in patients with advanced carcinoma: a phase I study. Mol Ther 11;149-159, 2005. https://doi.org/10.1016/j.ymthe.2004.09.019
  44. Miyahara R, Banerjee S, Kawano K, Efferson C, Tsuda N, Miyahara Y, Ioannides CG, Chada S, Ramesh R: Melanoma differentiation-associated gene-7 (mda-7)/interleukin (IL)-24 induces anticancer immunity in a syngeneic murine model. Cancer Gene Ther 13;753-761, 2006. https://doi.org/10.1038/sj.cgt.7700954
  45. Ansel KM, Lee DU, Rao A: An epigenetic view of helper T cell differentiation. Nat Immunol 4;616-623, 2003. https://doi.org/10.1038/ni0703-616
  46. Zhou L, Chong MM, Littman DR: Plasticity of CD4+ T cell lineage differentiation. Immunity 30;646-655, 2009. https://doi.org/10.1016/j.immuni.2009.05.001
  47. Zou YR, Sunshine MJ, Taniuchi I, Hatam F, Killeen N, Littman DR: Epigenetic silencing of CD4 in T cells committed to the cytotoxic lineage. Nat Genet 29;332-336, 2001. https://doi.org/10.1038/ng750
  48. Glimcher LH, Townsend MJ, Sullivan BM, Lord GM: Recent developments in the transcriptional regulation of cytolytic effector cells. Nat Rev Immunol 4;900-911, 2004. https://doi.org/10.1038/nri1490
  49. Lee CG, Sahoo A, Im SH: Epigenetic regulation of cytokine gene expression in T lymphocytes. Yonsei Med J 50;322- 330, 2009. https://doi.org/10.3349/ymj.2009.50.3.322
  50. Lee GR, Kim ST, Spilianakis CG, Fields PE, Flavell RA: T helper cell differentiation: regulation by cis elements and epigenetics. Immunity 24;369-379, 2006. https://doi.org/10.1016/j.immuni.2006.03.007
  51. Liu X, Bosselut R: Duration of TCR signaling controls CD4-CD8 lineage differentiation in vivo. Nat Immunol 5; 280-288, 2004. https://doi.org/10.1038/ni1040
  52. Madireddi MT, Dent P, Fisher PB: AP-1 and C/EBP transcription factors contribute to mda-7 gene promoter activity during human melanoma differentiation. J Cell Physiol 185; 36-46, 2000. https://doi.org/10.1002/1097-4652(200010)185:1<36::AID-JCP3>3.0.CO;2-V
  53. Madireddi MT, Dent P, Fisher PB: Regulation of mda-7 gene expression during human melanoma differentiation. Oncogene 19;1362-1368, 2000. https://doi.org/10.1038/sj.onc.1203424
  54. Otkjaer K, Holtmann H, Kragstrup TW, Paludan SR, Johansen C, Gaestel M, Kragballe K, Iversen L: The p38 MAPK regulates IL-24 expression by stabilization of the 3' UTR of IL-24 mRNA. PLoS One 5;e8671, 2010. https://doi.org/10.1371/journal.pone.0008671
  55. Fischer JJ, Toedling J, Krueger T, Schueler M, Huber W, Sperling S: Combinatorial effects of four histone modifications in transcription and differentiation. Genomics 91; 41-51, 2008. https://doi.org/10.1016/j.ygeno.2007.08.010
  56. Schubeler D, MacAlpine DM, Scalzo D, Wirbelauer C, Kooperberg C, van Leeuwen F, Gottschling DE, O'Neill LP, Turner BM, Delrow J, Bell SP, Groudine M: The histone modification pattern of active genes revealed through genome- wide chromatin analysis of a higher eukaryote. Genes Dev 18;1263-1271, 2004. https://doi.org/10.1101/gad.1198204
  57. Workman JL, Kingston RE: Alteration of nucleosome structure as a mechanism of transcriptional regulation. Annu Rev Biochem 67;545-579, 1998. https://doi.org/10.1146/annurev.biochem.67.1.545
  58. Wei L, Vahedi G, Sun HW, Watford WT, Takatori H, Ramos HL, Takahashi H, Liang J, Gutierrez-Cruz G, Zang C, Peng W, O'Shea JJ, Kanno Y: Discrete roles of STAT4 and STAT6 transcription factors in tuning epigenetic modifications and transcription during T helper cell differentiation. Immunity 32;840-851, 2010. https://doi.org/10.1016/j.immuni.2010.06.003
  59. Pan L, Pan H, Jiang H, Du J, Wang X, Huang B, Lu J: HDAC4 inhibits the transcriptional activation of mda-7/IL-24 induced by Sp1. Cell Mol Immunol 7;221-226, 2010. https://doi.org/10.1038/cmi.2010.12
  60. Sauane M, Gopalkrishnan RV, Sarkar D, Su ZZ, Lebedeva IV, Dent P, Pestka S, Fisher PB: MDA-7/IL-24: novel cancer growth suppressing and apoptosis inducing cytokine. Cytokine Growth Factor Rev 14;35-51, 2003. https://doi.org/10.1016/S1359-6101(02)00074-6
  61. Mhashilkar AM, Schrock RD, Hindi M, Liao J, Sieger K,Kourouma F, Zou-Yang XH, Onishi E, Takh O, Vedvick TS, Fanger G, Stewart L, Watson GJ, Snary D, Fisher PB, Saeki T, Roth JA, Ramesh R, Chada S: Melanoma differentiation associated gene-7 (mda-7): a novel anti-tumor gene for cancer gene therapy. Mol Med 7;271-282, 2001. https://doi.org/10.1007/s008940100028
  62. Egger G, Liang G, Aparicio A, Jones PA: Epigenetics in human disease and prospects for epigenetic therapy. Nature 429;457-463, 2004. https://doi.org/10.1038/nature02625
  63. Sharma S, Kelly TK, Jones PA: Epigenetics in cancer. Carcinogenesis 31;27-36, 2010. https://doi.org/10.1093/carcin/bgp220

Cited by

  1. Endothelial cell PTP1B regulates leukocyte recruitment during allergic inflammation vol.304, pp.4, 2012, https://doi.org/10.1152/ajplung.00375.2012
  2. Mda-7/IL-24 enhances sensitivity of B cell lymphoma to chemotherapy drugs vol.35, pp.5, 2012, https://doi.org/10.3892/or.2016.4622
  3. Screening and identification of proteins interacting with IL-24 by the yeast two-hybrid screen, Co-IP, and FRET assays vol.27, pp.4, 2012, https://doi.org/10.1097/cad.0000000000000343
  4. Mda-7/IL-24 induces the differentiation of B cell lymphoma via activation of the P38 mitogen activated protein kinase signaling pathway vol.16, pp.4, 2012, https://doi.org/10.3892/mmr.2017.7306
  5. Myeloid zinc finger 1 protein is a key transcription stimulating factor of PYROXD2 promoter vol.38, pp.5, 2012, https://doi.org/10.3892/or.2017.5990
  6. Cell-Specific Requirements for STAT Proteins and Type I IFN Receptor Signaling Discretely Regulate IL-24 and IL-10 Expression in NK Cells and Macrophages vol.200, pp.6, 2012, https://doi.org/10.4049/jimmunol.1701340
  7. Identification of FaNBS-encoding genes responsive to Colletotrichum fructicola infection in strawberry (Fragaria ×ananassa Duchase) vol.47, pp.5, 2012, https://doi.org/10.1007/s13313-018-0582-8